September 2021 - Page 21 of 35

TuesdaySep 14, 2021 10:51 am

Ammonia’s Potential as Clean Hydrogen Carrier Illustrates a Key Benefit of FuelPositive Corp. (TSX.V: NHHH) (OTCQB: NHHHF) Technology

Canadian-based growth-stage company FuelPositive Corp. is building prototypes for a commercially viable and sustainable clean energy ammonia production system that can enable the hydrogen economy by making the transportation and storage of hydrogen easy and economical Ammonia has been a carbon-intense industry, but FuelPositive’s Phase 2 Hydrogen-Ammonia Synthesizer is a highly portable and scalable patent-pending solution for rolling out a carbon-free, on site production model to end users A report by scientific and technological innovation magazine New Atlas weighs the potential benefits of using ammonia as a means of storing hydrogen for green energy, including ammonia’s ability to “do a…

TuesdaySep 14, 2021 9:42 am

QualityStocksNewsBreaks – DSG Global Inc. (DSGT) Announces First Production Launch of Imperium-Branded SEV Models

DSG Global (OTCQB: DSGT) today announced that its electric vehicle division, Imperium Motor Company, is commencing its initial production of 682 Imperium-branded Sport Electric Vehicle (“SEV”) models (previously known as the “ET5”). “With the presales deposits pace growing as well as the enthusiasm of our prospective retailers in North America and the imminent completion of the homologation process, we are now in a position to place our first monthly orders for the SEV,” said Christian Dubois, president, Imperium Canada. “We expect this first of three orders of vehicles for the quarter to begin arriving during the fourth quarter and will…

TuesdaySep 14, 2021 9:42 am

Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) Likely to Benefit from New Research Touting Psilocybin Mental Health Treatments

Yale researchers publish study that a single dose of psilocybin counteracts symptoms of depression Administering drug to mice resulted in an approximately 10% increase in neuron size and density Cybin is focused on progressing psychedelic therapeutics As news of psychedelic research continues to report breakthroughs — such as the recent news from a group of Yale researchers that a single dose of psilocybin counteracts symptoms of depression (https://ibn.fm/NCORl) — companies operating in the space, including Cybin (NEO: CYBN) (NYSE American: CYBN), are ideally positioned to see significant benefits and growth. “Yale researchers found that a single dose of the naturally occurring psychedelic compound psilocybin…

TuesdaySep 14, 2021 9:03 am

SRAX Inc. (NASDAQ: SRAX) Gears up for Its First Ever 2021 Sequire EdTech Conference, Announces EdTech Heavyweights as Keynote Speakers

2021 Sequire EdTech Conference announces keynote speaker lineup and agenda featuring founders and leaders of EdTech big names such as Udemy, HolonIQ, Amesite, and more Online education and remote work sector have exploded over the past years, attracting growing attention from investors Conference aims to bring this growing sector closer to diverse investor audiences, including institutional and retail investors, family offices, venture capitalists and private equity firms, and public and emerging growth companies SRAX (NASDAQ: SRAX), a financial technology company that developed Sequire, a SaaS platform designed to unlock data and insights for publicly traded companies, has announced an impressive…

MondaySep 13, 2021 3:27 pm

QualityStocksNewsBreaks – Brain Scientific Inc. (BRSF) Poised to Offer Solution to Rising Challenge Facing Global Health Systems

Brain Scientific (OTCQB: BRSF), a commercial-stage medical device and software company, offers next-generation technological solutions for the neurology market. The company’s two FDA-cleared devices, NeuroCap(TM) and NeuroEEG(TM), allow quick and reliable EEG testing in minutes and by any health care worker, not only specialized neurological technicians, bringing brain diagnostics to settings in which neurological testing was previously impossible or difficult. “As we learn more about COVID-19, it is becoming increasingly clear that neurological care in the post-COVID world will be crucial,” reads a recent article. This revelation comes amid findings by scientists who are starting to collect more and more…

MondaySep 13, 2021 3:17 pm

QualityStocksNewsBreaks – AmpliTech Group Inc. (NASDAQ: AMPG) Achieves Significant YOY Increases in Revenue, Gross Profits

AmpliTech Group (NASDAQ: AMPG), a state-of-the-art radio frequency (“RF”) signal component developer, has seen growing attention to its IP for satellite and 5G communications networks following its Nasdaq uplisting this year and its more recent inclusion on the Russell Microcap Index. “The company reported growth in its year-over-year and sequential quarterly revenues and gross profits when it released Q2 financial figures for the period ending June 30,” reads a recent article discussing AmpliTech’s performance. “The company also recently reported a Q2 2021 revenue of $1,024,410 signifying a 55% increase from Q2’20 revenue of $660,699. AmpliTech’s gross profits rose 52.5% to…

MondaySep 13, 2021 3:06 pm

QualityStocksNewsBreaks – InnerScope Hearing Technologies Inc. (INND) to Be Featured in ‘New to the Street’ Broadcast

InnerScope Hearing Technologies (OTC: INND) will be featured in an upcoming segment of FMW Media’s “New to the Street” nationally syndicated program. The company will be one of five featured on Tuesday, Sept. 14, 2021, with the broadcast airing at 10:30 p.m. PT on Fox Business Network. The segment will include another interview with INND CEO Matthew Moore, continuing to inform viewers about the company’s emerging and disruptive leadership in the “direct-to-consumer hearing technology” space. Moore explains his successful direct marketing strategy, helping provide consumers with the company’s hearing aids, selling at a fraction of the cost of those sold by the…

MondaySep 13, 2021 2:58 pm

Lexaria Bioscience Corp. (NASDAQ: LEXX) Impressive Blood Pressure Reduction in Hypertension Clinical Trials

Lexaria Bioscience has developed a patented technology that improves the bioavailability of pharmaceuticals and therapeutics in part by bypassing first-pass-liver processing Lexaria’s patented DehydraTECH (TM) technology is undergoing human clinical trials this year to determine its effectiveness in making cannabidiol (“CBD”) effective as a means of reducing blood pressure for high blood pressure patients The initial results of the first human clinical study showed the DehydraTECH-CBD compound was well tolerated by patients without troubling side effects and that the compound outperformed generic CBD controls Just-released initial (partial) results regarding the compound’s second human clinical trial show that a three-dose regimen…

MondaySep 13, 2021 2:48 pm

QualityStocksNewsBreaks – PlantX Life Inc. (CSE: VEGA) (Frankfurt: WNT1) (OTCQB: PLTXF) Announces Plans to Launch Products on Amazon Marketplace

PlantX Life (CSE: VEGA) (Frankfurt: WNT1) (OTCQB: PLTXF) is in the process of launching as a seller on Amazon Marketplace. The company will be a seller on both the U.S. and Canadian sides of the online store well-recognized multinational e-commerce platform. According to the announcement, PlantX plans to utilize the Amazon Marketplace platform and back-end infrastructure to list and sell its plant-based items; the company will also use Amazon services to fulfill customer orders. As a seller, PlantX will have access to Amazon’s well-established fulfillment resources, customer service and extensive network of affiliates. “Launching on the Amazon platform is a great opportunity…

MondaySep 13, 2021 2:28 pm

QualityStocksNewsBreaks – SRAX Inc. (NASDAQ: SRAX) to Issue One-Time Special Dividend to Shareholders of Record

SRAX (NASDAQ: SRAX), a financial technology company that unlocks data and insights for publicly traded companies through Sequire, its software-as-a-service (“SaaS”) platform, today announced that it will be issuing a one-time special dividend to shareholders of record on Sept. 20, 2021. The company reported Q2 revenue of $7.7M, up 557% year-over-year, 41% sequentially quarter-over-quarter, in addition to Q2 Sequire bookings of $11.4 million in its Q2 2021 earnings report. Following the report and exponential growth, SRAX also announced a $10 million stock buy-back program and a one-time special dividend to be issued to shareholders of record. SRAX will be issuing non-tradable…

Site Search

Company Search

Month: September 2021